RESPECT And PC Trial Results In, But Still No Real ‘Closure’ On PFO

There was some expectation leading up to TCT that the two trials could provide a definitive ruling on whether the PFO closure procedure had a future or not. But actual outcomes sparked a range of interpretations.

Industry watchers looking for a clear answer on the fate of the market for patent foramen ovale closure as a stroke treatment at this year’s Transcatheter Cardiovascular Therapeutics annual conference were likely disappointed.

The results from two hotly anticipated studies evaluating St. Jude Medical Inc.’s Amplatzer PFO occluder for patent foramen ovale closure sparked a range of interpretations from practitioners at the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D